a16z Perennial Management L.P. Acquires New Shares in Omada Health, Inc. $OMDA

a16z Perennial Management L.P. acquired a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 157,132 shares of the company’s stock, valued at approximately $2,480,000.

A number of other institutional investors have also recently bought and sold shares of OMDA. BIT Capital GmbH acquired a new position in shares of Omada Health during the 3rd quarter worth about $13,639,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Omada Health during the 4th quarter worth about $1,222,000. Divisadero Street Capital Management LP acquired a new position in shares of Omada Health during the 3rd quarter worth about $30,510,000. Madryn Asset Management LP acquired a new position in shares of Omada Health during the 4th quarter worth about $9,212,000. Finally, Fortress Investment Group LLC lifted its position in shares of Omada Health by 43.1% during the 3rd quarter. Fortress Investment Group LLC now owns 225,000 shares of the company’s stock worth $4,975,000 after purchasing an additional 67,750 shares during the last quarter.

Insider Activity

In other news, President Wei-Li Shao sold 2,829 shares of the company’s stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $12.71, for a total value of $35,956.59. Following the sale, the president directly owned 328,850 shares in the company, valued at approximately $4,179,683.50. This represents a 0.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer directly owned 117,598 shares in the company, valued at $1,686,355.32. The trade was a 3.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 8,776 shares of company stock worth $120,483. Company insiders own 6.38% of the company’s stock.

Omada Health Stock Performance

OMDA stock opened at $17.97 on Monday. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $28.40. The firm has a market cap of $1.07 billion and a P/E ratio of -66.56. The business’s 50 day moving average is $14.39 and its 200-day moving average is $14.93.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. Sell-side analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Evercore restated an “outperform” rating and set a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Friday, May 8th. Wall Street Zen lowered Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday. BMO Capital Markets lowered their price target on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Finally, Wells Fargo & Company boosted their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.